论文部分内容阅读
目的探讨电子止吐仪在乳癌患者化疗护理干预中的应用对焦虑、抑郁情绪及化疗依从性的影响。方法选择2013年6月—2014年5月收治的120例按CE方案化疗的乳癌患者作为研究对象,随机分为对照组和试验组各60例。对照组在化疗过程中实行常规护理干预,试验组在常规护理干预的基础上加用电子止吐仪。观察和记录两组患者化疗前后负性情绪改善情况以及化疗依从性情况。计量资料组间比较采用t检验,组内比较采用配对t检验,计数资料采用χ2检验,P<0.05为差异有统计学意义。结果试验组和对照组化疗后焦虑自评量表(self-rating anxiety scale,SAS)和抑郁自评量表(self-rating depression scale,SDS)得分分别为(52.51±7.01)、(43.23±6.86)、(58.16±6.96)、(51.09±5.37)分,均较化疗前的(63.9 3±7.31)、(64.31±6.9 7)、(67.83±7.51)、(68.51±7.07)分降低,差异均有统计学意义(均P<0.05)。化疗后,试验组SAS、SDS得分均低于对照组,差异均有统计学意义(均P<0.05)。试验组患者化疗依从率为91.67%,高于对照组的75.00%,差异有统计学意义(P<0.05)。结论电子止吐仪应用于乳癌化疗中,对减轻患者胃肠道反应疗效显著,可减轻患者的负性情绪,提高患者对化疗的依从性。
Objective To investigate the effect of electronic antiemetic device on anxiety, depression and chemotherapy compliance in chemotherapy and nursing intervention of breast cancer patients. Methods From June 2013 to May 2014, 120 patients with breast cancer who underwent chemotherapy with CE regimen were randomly divided into control group and test group of 60 cases. In the control group, routine nursing intervention was carried out in the course of chemotherapy. The experimental group added the electronic antiemetic device on the basis of routine nursing intervention. To observe and record the two groups of patients before and after chemotherapy, the improvement of negative emotions and chemotherapy compliance. Measurement data were compared between groups using t test, the group was compared using paired t test, count data using χ2 test, P <0.05 for the difference was statistically significant. Results The scores of self-rating anxiety scale (SAS) and self-rating depression scale (SDS) in the experimental group and the control group after chemotherapy were (52.51 ± 7.01) and (43.23 ± 6.86 ), (58.16 ± 6.96) and (51.09 ± 5.37) points lower than those before chemotherapy (63.9 3 ± 7.31), (64.31 ± 6.97), (67.83 ± 7.51) and (68.51 ± 7.07) There was statistical significance (all P <0.05). After chemotherapy, SAS and SDS scores in the experimental group were lower than those in the control group (all P <0.05). The compliance rate of chemotherapy in the experimental group was 91.67%, which was higher than that in the control group (75.00%), the difference was statistically significant (P <0.05). Conclusion Electronic antiemetic device used in breast cancer chemotherapy, to reduce gastrointestinal reactions in patients with significant effect, can reduce the patient’s negative emotions and improve patient compliance with chemotherapy.